LMNA and Hutchinson-Gilford progeria syndrome: In this report, we have provided evidence that Progerinin intake has therapeutic potential for HGPS-related cardiovascular dysfunction and histological defects by targeting progerin suggesting that the cardiovascular disease of HGPS patients can be improved.